臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 51841680 線上人數 : 1017 教育部委託研究計畫計畫執行:國立臺灣大學圖書館

搜尋範圍

進階搜尋

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"wu j y"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 316-325 / 599 (共60頁)
<< < 27 28 29 30 31 32 33 34 35 36 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-05-26T09:27:23Z	Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response	Yang P.-C.;Shin J.-Y;Yu C.-J;Chang Y.-L;Gow C.-H;Chih-Hsin Yang;Wu S.-G;Wu J.-Y; Wu J.-Y; Wu S.-G; CHIH-HSIN YANG; Gow C.-H; Chang Y.-L; Yu C.-J; Shin J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:21Z	First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer	Yang P.-C.;Shih J.-Y;Wei P.-F;Hsu Y.-C;Chang Y.-C;Gow C.-H;Chiu Y.-H;Wu S.-G;Chih-Hsin Yang;Yu C.-J;Wu J.-Y; Wu J.-Y; Yu C.-J; CHIH-HSIN YANG; Wu S.-G; Chiu Y.-H; Gow C.-H; Chang Y.-C; Hsu Y.-C; Wei P.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:21Z	Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern	Yang P.-C.;Shih J.-Y;Tsai M.-F;Yu C.-J;Chih-Hsin Yang;Wu J.-Y;Hsu Y.-C;Chang Y.-L;Wu S.-G; Wu S.-G; Chang Y.-L; Hsu Y.-C; Wu J.-Y; CHIH-HSIN YANG; Yu C.-J; Tsai M.-F; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:18Z	Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer	Wu J.-Y;Shih J.-Y;Chih-Hsin Yang;Chen K.-Y;Ho C.-C;Yu C.-J;Yang P.-C.; Wu J.-Y; Shih J.-Y; CHIH-HSIN YANG; Chen K.-Y; Ho C.-C; Yu C.-J; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:16Z	Use of cetuximab after failure of gefitinib in patients with advanced non-small-cell lung cancer	Shih J.-Y; Chang S.-H; Yu C.-J; Hsu Y.-C; CHIH-HSIN YANG; Wu J.-Y; Wu J.-Y;Chih-Hsin Yang;Hsu Y.-C;Yu C.-J;Chang S.-H;Shih J.-Y;Yang P.-C.; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:16Z	Influence of first-line chemotherapy and EGFR mutations on second-line gefitinib in advanced non-small cell lung cancer	Wu J.-Y;Yu C.-J;Shih J.-Y;Chih-Hsin Yang;Yang P.-C.; Wu J.-Y; Yu C.-J; Shih J.-Y; CHIH-HSIN YANG; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:13Z	Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations	Wu J.-Y;Wu S.-G;Chih-Hsin Yang;Chang Y.-L;Chang Y.-C;Hsu Y.-C;Shih J.-Y;Yang P.-C.; Wu J.-Y; Wu S.-G; CHIH-HSIN YANG; Chang Y.-L; Chang Y.-C; Hsu Y.-C; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:12Z	Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations	Wu J.-Y;Shih J.-Y;Chen K.-Y;Chih-Hsin Yang;Yu C.-J;Yang P.-C.; Wu J.-Y; Shih J.-Y; Chen K.-Y; CHIH-HSIN YANG; Yu C.-J; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:12Z	Effectiveness of tyrosine kinase inhibitors on "uncommon" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer	Wu J.-Y;Yu C.-J;Chang Y.-C;Chih-Hsin Yang;Shih J.-Y;Yang P.-C.; Wu J.-Y; Yu C.-J; Chang Y.-C; CHIH-HSIN YANG; Shih J.-Y; Yang P.-C.
臺大學術典藏	2020-05-26T09:27:07Z	Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR	Yang P.-C.;Shih J.-Y;Wei P.-F;Yu C.-J;Chih-Hsin Yang;Wu J.-Y;Wu S.-G;Chung K.-P; Chung K.-P; Wu S.-G; Wu J.-Y; CHIH-HSIN YANG; Yu C.-J; Wei P.-F; Shih J.-Y; Yang P.-C.

顯示項目 316-325 / 599 (共60頁)
<< < 27 28 29 30 31 32 33 34 35 36 > >>
每頁顯示[10|25|50]項目